INSIGHTS ON DRUG DEVELOPMENT

• Quality By Design And Affinity Chromatography

  As the industry utilizes more sophisticated protein structures in complex biologics development, how do we optimize the affinity chromatography step to ensure higher yields for more efficient biomanufacturing at scale?

• Genomic Medicine Drug Discovery And Screening, A Digital Era For RNA-LNP Therapeutics

  Learn about the key stages of drug discovery and screening along with how to overcome key bottlenecks in screening mRNA-LNPs to rapidly develop genomic medicines.

• Generating A Robust Host Cell Line For A Cell Line Development Platform

  Learn how cell performance within the context of the cell line development workflow was confirmed with the successful isolation of stable, high-producing clones from three model monoclonal antibodies.

• Solubility With Lipid-Based Technologies For Oral & Injectable Formulations

  Explore the decision for selecting the right and most suited technology for formulating a complex molecule.

• De-Risking A Bioconjugate’s Development Path From Discovery To Clinic

  11/4/2022

  Understanding the obstacles you may face during bioconjugate development, as well as the tools available to help overcome them, can help streamline your product’s path to market.

• Bringing Allogeneic Cell Therapy To Patient Care

  11/1/2022

  Bringing allogeneic cell therapy to patient care will require flexible, closed, and automated solutions to support the treatment options and increasing scale of the industry.

• Multi-Attribute Method Analysis: Moving Toward The Mainstream For Biotherapeutic Development

  11/1/2022

  Employing the Multi-Attribute Method (MAM) based on liquid chromatography-mass spectrometry (LC-MS) analysis of biotherapeutics represents a critical advancement in evaluating the increasing complexity of biotherapeutic molecules.

• Scaling Up Your Methods with USP <621> - Part 3: Software

  10/31/2022

  Learn about modifications to certain calculations and how they will be addressed using our software along with how relevant naming conventions and calculations will be maintained to help customers.